Charleston, SC -- (SBWIRE) -- 12/09/2013 -- otcstockcenter.com, provide information specifically for trades in the micro cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Lets have a look on Few Hot Stocks, Endeavor IP Inc(OTCBB:ENIP), Paid, Inc.(OTCMKTS:PAYD), Savient Pharmaceuticals Inc(OTCMKTS:SVNTQ), Titan Pharmaceuticals, Inc.(OTCBB:TTNP)
Endeavor IP Inc(OTCBB:ENIP) finished last trade at $0.625, losing -9.42%. Trading volume recorded for this company was about 119,691.00 shares as compared to its average volume of 528,891.00 shares. The share price plunged almost -48.35% in the last one month while its 52 week high is $1.28. The company has the total of 42.80 million outstanding shares while its market capitalization is now about $26.75 million. Endeavor IP, Inc. engages in the provision of consulting services, installation, and sale of accessibility and safety products for residential and commercial buildings that require access by handicapped individuals or individuals with limited joint mobility.
Has ENIP Found The Bottom and Ready To Move Up? Find Out Here
Paid, Inc.(OTCMKTS:PAYD) closed at $0.149, up +10.74%, on volume of over 1.17 million shares. The share price went up 86.88% in the last 5 days. The company has an average trading volume of 260,537.00 shares. In the time frame of the last one month, shares surged almost 76.09%. Its market capitalization was $49.17 million. PAID, Inc. focuses on providing brand-related services to businesses and celebrity clients in the entertainment industry, and charitable organizations.
For How Long PAYD will Fight for Profitability? Read This Trend Analysis report
Savient Pharmaceuticals Inc(OTCMKTS:SVNTQ) traded with -17.39% lost momentum to $0.0190 in the latest trading session It captured $1.39 million in market value. The total number of shares traded on the latest trading day was about 1.08 million shares. The day started out with an opening price of $0.02 and changed hands at price range of $0.02 to $0.02 apiece. Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company in the United States.
Why Should Investors Buy SVNTQ After the Recent Fall ? Just Go Here and Find Out
Titan Pharmaceuticals, Inc.(OTCBB:TTNP) ended recent trading day at $0.710, losing -1.39%.The total number of shares traded on the latest trading day was about 81,757.00 shares. In the last 5 days it showed a drop of -7.55% and on its one month graph, shares are -3.53% down. The stock has a 52-week high price of $2.53 and its 52-week low was recorded at $0.32. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
Will TTNP Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)